Yan Niu | Pharmaceutical Chemistry | Research Excellence Award

Published on by Top Pharmaceutical

Prof. Yan Niu | Pharmaceutical Chemistry | Research Excellence Award

Peking University | China

Prof. Yan Niu has established a solid and credible scholarly footprint within the global pharmaceutical sciences community, as demonstrated by his citation performance and publication metrics. His research portfolio comprises 46 peer-reviewed scientific documents, published in reputable international journals indexed in major databases such as Scopus and SCI. These publications collectively have attracted 538 citations, reflecting sustained academic attention and continued relevance of his work. Importantly, these citations originate from 447 independent citing documents, indicating that his research has been widely referenced across diverse studies rather than concentrated within a narrow citation network.An h-index of 14 further illustrates the balance between productivity and impact in Prof. Niu’s academic career. This metric signifies that at least fourteen of his publications have each received a minimum of fourteen citations, underscoring consistent influence across multiple research outputs rather than reliance on a small number of highly cited papers. Such a profile is characteristic of researchers whose work contributes foundational knowledge and methodological innovation to their field.The citation impact of Prof. Niu’s publications is closely aligned with the scientific significance of his research areas, particularly targeted protein degradation, amino acid-based hydrophobic tagging strategies, and the discovery and optimization of biologically active small molecules. These topics are at the forefront of modern drug discovery, attracting interdisciplinary interest from medicinal chemists, pharmacologists, and translational researchers. Collectively, his citation metrics not only quantify academic recognition but also reflect the practical and conceptual value of his contributions to advancing innovative therapeutic strategies and expanding the chemical biology toolkit available to pharmaceutical research.

Citation Metrics (Scopus)

600

450

300

150

0

Citations
538

Documents
46

h-index
14


View Scopus Profile

Featured Publications

Liangqun Li | Pharmaceutical Chemistry | Best Researcher Award

Published on by Top Pharmaceutical

Dr. Liangqun Li | Pharmaceutical Chemistry | Best Researcher Award

Natural Products Research Center of Guizhou Province | China

Dr. Liangqun Li is a distinguished researcher in natural products chemistry, medicinal chemistry, and functional natural product development, widely recognized for his contributions to the scientific understanding of bioactive plant compounds, particularly those derived from Guizhou’s characteristic botanical resources such as Rosa roxburghii. As a Researcher at the Guizhou Research Center for Natural Products, the National Key Laboratory of Efficacy Components of Traditional Chinese Medicine and Their Utilization, and the Institute of Functional Natural Products, he leads high-impact investigations into efficacy material basis, molecular pathways, and translational utilization of natural compounds. Dr. Li’s scholarly influence is reflected in his strong research metrics, with 293 citations from 275 citing documents, 35 published documents, and an h-index of 11, underscoring his growing global impact in the fields of natural products, phytochemistry, and medicinal biosciences. Before his current role, he completed a productive postdoctoral fellowship at the Key Laboratory of Plant Resources & Biotechnology, Kunming Institute of Botany, Chinese Academy of Sciences, advancing the identification and functional analysis of key genes involved in pennogenin saponin biosynthesis in Paris polyphylla var. yunnanensis. His earlier experience as an R&D Specialist at Yunnan Baiyao Group strengthened his expertise in pharmaceutical formulation, chemical generic drug development, innovative health-care products, and applied medicinal chemistry. Dr. Li earned his Doctor of Science in Medicinal Chemistry from the Kunming Institute of Botany in collaboration with Yunnan University, preceded by a Master of Pharmacy and a Bachelor of Pharmacy from Kunming Medical University and Haiyuan College. His scholarly contributions include significant publications such as Effects and formula optimization of Rosa roxburghii pomace substrate on the yield and volatile flavor compounds of Lentinula edodes, Therapeutic potential of Rosa roxburghii folium extract in insomnia treatment, Combined metabolite and transcriptomic profiling unveil a potential gene network involved in the triterpenoid metabolism of Rosa roxburghii, Acer truncatum seed oil and Rosa roxburghii juice submicron emulsion: preparation and its therapeutic potential in alleviating scopolamine-induced memory impairment in mice, Isolation, identification, phytochemical characterization and in vitro anti-inflammatory property of an endophytic Trametes versicolor CL-1 isolated from Rosa roxburghii, In vitro neurotrophic properties and structural characterization of a new polysaccharide LTC-1 from Pyrola corbieri Levl, Effect on hypoglycemic activity and UPLC-MS/MS profiling of Rosa roxburghii fruit fermented with Chinese traditional distiller’s yeast, Preparation and characterization of calcium-incorporated Rosa roxburghii Tratt and its efficacy on bone mineral density in rats, Microbial transformation of diosgenin to diosgenone by Wickerhamomyces anomalus JQ-1, and multiple works on asymmetric total synthesis of natural product derivatives including triptophenolide, triptolide, dichroanone, taiwaniaquinone H, brazilin, brazilein, and brazilide A. Through his integrated research combining metabolomics, transcriptomics, biosynthesis, phytochemistry, and innovative natural product engineering, Dr. Li continues to advance the scientific landscape of medicinal plants, contributing to novel therapeutic insights, biochemical pathway discovery, and the modernization of traditional medicinal resources.

Profile: Scopus

Featured Publications

Authors. (2025). Targeted discovery of oxygen-bridged sesquiterpenes from Cinnamomum migao by MS/MS-based molecular networking and their neuroprotective activities. Phytochemistry.

Authors. (2025). Iridoid constituents and anti-aging activity of Eucommiae Folium. Shipin Kexue Food Science.

Authors. (2025). Therapeutic potential of Rosa roxburghii folium extract in insomnia treatment: A comprehensive evaluation of behavioral and neurochemical effects in a PCPA-induced mouse model. Journal of the Science of Food and Agriculture.

Amirhosein Kefayat | Pharmaceutical Chemistry | Top Pharmaceutical Scientist Award

Published on by Top Pharmaceutical

Dr. Amirhosein Kefayat | Pharmaceutical Chemistry | Top Pharmaceutical Scientist Award

Edinburgh of University | United Kingdom

Dr. Amirhosein Kefayat is a distinguished physician-scientist specializing in oncology, nanomedicine, cancer immunotherapy, and radiation oncology, with extensive experience in translational research and clinical studies. He earned his Doctorate of Medicine (MD) from Isfahan University of Medical Sciences in 2019 and has since advanced his qualifications with multiple prestigious certifications, including full registration with the General Medical Council (UK) and ongoing ECFMG certification for the United States.Currently serving as a Clinical Research Fellow at the Institute of Genetics & Cancer, University of Edinburgh & NHS Lothian (UK), Dr. Kefayat contributes to UK-wide clinical trials such as ACESO, BIOPIC, DEFINE, PROFILE, PAN-IBD, and Gut Cell Atlas. He also leads systematic review and meta-analysis teams, influencing major clinical guidelines like the British Society of Gastroenterology 2024 update.Previously, as a Clinical Research Fellow at the Dept. of Radiotherapy & Oncology, Arak University of Medical Sciences (Iran), he led multiple high-impact research projects, resulting in numerous publications, international conference presentations, patents, and national research grants (INSF, NIMAD).Dr. Kefayat has published extensively in top Q1 journals such as Carbohydrate Polymers, Biosensors & Bioelectronics, Vaccine, Scientific Reports, Journal of Biomolecular Structure & Dynamics, and Nanomedicine. His work on novel cancer vaccines, wound healing biomaterials, and radiosensitizers ranks among the top 1–10% most-cited papers worldwide, reflecting his global research impact.His notable accolades include recognition as the top 0.5% of scholars worldwide (2024), membership in Iran’s National Elites Foundation, and multiple national research grants. His patented biomaterial for diabetic wound healing demonstrates his commitment to bridging laboratory research with clinical application.

Profile: Google Scholar

Featured Publications

Eskandarinia, A., Kefayat, A., Agheb, M., Rafienia, M., & Amini Baghbadorani, M. (2020). A novel bilayer wound dressing composed of a dense polyurethane/propolis membrane and a biodegradable polycaprolactone/gelatin nanofibrous scaffold. Scientific Reports, 10(1), 3063.

Eskandarinia, A., Kefayat, A., Gharakhloo, M., Agheb, M., Khodabakhshi, D., Rafienia, M., & Navid, S. (2020). A propolis enriched polyurethane-hyaluronic acid nanofibrous wound dressing with remarkable antibacterial and wound healing activities. International Journal of Biological Macromolecules, 149, 467–476.

Safavi, A., Kefayat, A., Mahdevar, E., Abiri, A., & Ghahremani, F. (2020). Exploring the out of sight antigens of SARS-CoV-2 to design a candidate multi-epitope vaccine by utilizing immunoinformatics approaches. Vaccine, 38(48), 7612–7628.

Khodabakhshi, D., Eskandarinia, A., Kefayat, A., Rafienia, M., Navid, S., & Agheb, M. (2019). In vitro and in vivo performance of a propolis-coated polyurethane wound dressing with high porosity and antibacterial efficacy. Colloids and Surfaces B: Biointerfaces, 178, 177–184.

Eskandarinia, A., Kefayat, A., Rafienia, M., Agheb, M., Navid, S., & Ebrahimpour, K. (2019). Cornstarch-based wound dressing incorporated with hyaluronic acid and propolis: In vitro and in vivo studies. Carbohydrate Polymers, 216, 25–35.

Karizmeh, M. S., Poursamar, S. A., Kefayat, A., Farahbakhsh, Z., & Rafienia, M. (2022). An in vitro and in vivo study of PCL/chitosan electrospun mat on polyurethane/propolis foam as a bilayer wound dressing. Biomaterials Advances, 135, 112667.

Ghahremani, F., Shahbazi-Gahrouei, D., Kefayat, A., Motaghi, H., & Amouheidari, A. (2018). AS1411 aptamer conjugated gold nanoclusters as a targeted radiosensitizer for megavoltage radiation therapy of 4T1 breast cancer cells. RSC Advances, 8(8), 4249–4258.

Safavi, A., Kefayat, A., Abiri, A., Mahdevar, E., Behnia, A. H., & Ghahremani, F. (2019). In silico analysis of transmembrane protein 31 (TMEM31) antigen to design novel multiepitope peptide and DNA cancer vaccines against melanoma. Molecular Immunology, 112, 93–102.

Shu-Rong Ban | Pharmaceutical Chemistry | Excellence in Research Award

Published on by Top Pharmaceutical

Prof. Shu-Rong Ban | Pharmaceutical Chemistry | Excellence in Research Award

Shanxi Medical University | China

Prof. Shu-Rong Ban is a distinguished scholar in the field of medicinal chemistry with a solid academic foundation and a long-standing commitment to research, teaching, and scientific innovation. He began his academic journey at Tianjin Normal University, where he obtained his bachelor’s degree, and later pursued a combined master’s and doctoral program at Nankai University, successfully earning his doctorate. His professional career has been deeply rooted in the School of Pharmacy at Shanxi Medical University, where he advanced through the ranks from lecturer to associate professor and later professor, reflecting his dedication and contributions to the field. He also enriched his academic perspective through international exposure as a visiting scholar at McGill University in Canada and at the Beijing Institute of Technology, experiences that expanded his research horizons and fostered collaborative ties with leading researchers worldwide.Prof. Ban has been actively involved in academic leadership and professional service. He holds memberships and leadership positions in multiple professional organizations, including serving as a member of the Pharmacy Education Professional Committee of the Chinese Pharmaceutical Association, director of the Shanxi Pharmaceutical Association, deputy director of its Academic Working Committee, and director of the Shanxi Chemical Society. His academic excellence has been recognized through honors such as the Shanxi Provincial Science and Technology Progress Award, the “Three Educations” Advanced Individual Award of Shanxi Medical University, and the Excellent Graduate Tutor distinction, reflecting both his research achievements and commitment to education.In teaching, Prof. Ban has played a key role in shaping pharmacy education, offering undergraduate courses such as Organic Chemistry, Organic Chemistry Experiment, and Professional English, as well as postgraduate courses including Progress in Pharmacy, Introduction to the Frontier of Medicinal Chemistry, and Pharmaceutical Preparation Technology. Notably, his course on Organic Chemistry was selected as a Shanxi Provincial First-Class Course, highlighting his innovation in teaching methodology and curriculum design.

Profile: Orcid

Featured Publications

Guo, L., Kang, S., Liu, J., Ma, Y., Tian, Y., Wang, B., Ma, S., Li, L., Yan, L., Zhang, C., & Liu, W., et al. (2024). Activatable near-infrared fluorescent/photoacoustic probe for rapid identification of β-lactam-resistant bacteria. Microchemical Journal.

Ge, R., Song, J., Cao, Z., Ban, S., Tang, L., & Li, Q. (2024). Discovery of 6-acylamino/sulfonamido benzoxazolone with IL-6 inhibitory activity as promising therapeutic agents for ulcerative colitis. Chemistry & Biodiversity.

Liu, J., Li, X., Xie, S., Ma, R., Wang, H., Ban, S., Zhang, C., & Guo, L. (2024). Fabricating a PDA-NOate@CuS coated NIR-activatable titanium implant to realize simultaneous antiinfection and osseointegration. New Journal of Chemistry.

Yao, J., Li, C., Feng, J., Wei, B., Xing, R., Ban, S., Tang, L., & Liu, B. (2024). Mn-doped CeO₂ nanorods for the colorimetric sensing of glutathione. ACS Applied Nano Materials.

Liu, Y., Fu, Z., Yang, C., Luo, M., Ban, S., & Wang, S. (2024). Rh(III)-catalyzed aminoalkylation of alkenes with diazo compounds toward functionalized isoindolinones. Chinese Journal of Organic Chemistry.

Meng, S., Cao, Z., Bai, H., Ge, R., Ban, S., Tang, L., & Li, Q. (2023). Antinociceptive action of 4-(5′-dimethylamino)-naphthalenesulfonyl-2(3H)-benzoxazolone (W3D) on animal models of pain via inhibitory effects on NO and iNOS. Natural Product Communications.

Li, G., Zhang, H., Zhang, G., Wei, B., Liu, B., Song, H., Li, Q., & Ban, S. (2023). Asymmetric synthesis of spiropyrazolone-fused dihydrofuran-naphthoquinones bearing contiguous stereocenters via a Michael addition/chlorination/nucleophilic substitution sequence. Journal of Organic Chemistry.